These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 8108924

  • 1. Five years' experience with quadruple sequential immunosuppression.
    Fischbach M, Wolff P, Tongio MM, Boudjema K, Christmann D, Steib A, Sauvage P, Desprez P, Mengus L, Simeoni U.
    Transplant Proc; 1994 Feb; 26(1):17. PubMed ID: 8108924
    [No Abstract] [Full Text] [Related]

  • 2. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S, Kling N, Bechstein WO, Blumhardt G, Lohmann R, Lobeck H, Neuhaus P.
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [Abstract] [Full Text] [Related]

  • 3. Prevention of rejection and graft loss with an aggressive quadruple immunosuppressive therapy regimen in children and adolescents.
    Conley SB, al-Uzri A, So S, Salvatierra O.
    Transplantation; 1994 Feb 27; 57(4):540-4. PubMed ID: 8116038
    [Abstract] [Full Text] [Related]

  • 4. Cessation of steroids in pediatric renal transplant recipients treated with cyclosporine, azathioprine, and prednisolone.
    Francis DM, Walker RG, Jones C, Powell H.
    Transplant Proc; 1994 Feb 27; 26(1):99-101. PubMed ID: 8109043
    [No Abstract] [Full Text] [Related]

  • 5. Is induction therapy necessary for successful simultaneous pancreas and kidney transplantation in the cyclosporine era?
    Brayman KL, Egidi MF, Naji A, Friedman AL, Holland MT, Tomaszewski JE, Samini F, Perloff J, Grossman R, Barker CF.
    Transplant Proc; 1994 Oct 27; 26(5):2525-7. PubMed ID: 7940776
    [No Abstract] [Full Text] [Related]

  • 6. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.
    Bakr MA, Sally S, Foda MA, Sobh MA, el-Sherif AK, Ghoneim MA.
    Transplant Proc; 1994 Dec 27; 26(6):3163-6. PubMed ID: 7998104
    [No Abstract] [Full Text] [Related]

  • 7. Prospective randomized study of triple vs conventional immunosuppression in living donor kidney transplantation.
    Ghoneim MA, Sobh MA, Shokeir AA, Bakr MA, el-Sherif A, Foda MA.
    Transplant Proc; 1993 Jun 27; 25(3):2243-5. PubMed ID: 8516887
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Triple therapy including cyclosporine A versus conventional regimen--a randomized prospective study in pediatric kidney transplantation.
    Broyer M, Gagnadoux MF, Guest G, Niaudet P.
    Transplant Proc; 1987 Oct 27; 19(5):3582-5. PubMed ID: 3313862
    [No Abstract] [Full Text] [Related]

  • 11. Improved results using pediatric cadaver donor kidneys with cyclosporine immunosuppression.
    Hayes JM, Novick AC, Steinmuller DR, Streem SB, Hodge EE, Bretan PN, Cunningham R, Graneto D.
    Transplant Proc; 1988 Jun 27; 20(3 Suppl 3):209-14. PubMed ID: 3291245
    [No Abstract] [Full Text] [Related]

  • 12. Cyclosporine improves results in HLA-identical sibling renal transplants.
    Van Buren D, MacDonell R, Johnson HK, Richie R, Ynares C, Helderman JH, Green W, Crowe D.
    Transplant Proc; 1994 Oct 27; 26(5):2514-5. PubMed ID: 7940772
    [No Abstract] [Full Text] [Related]

  • 13. Successful pancreas-renal transplantation without anti-T-cell antibody induction.
    Shapiro ME, Abrams JM, Brown RS, Steinman TI, Strom TB.
    Transplant Proc; 1995 Dec 27; 27(6):3087-8. PubMed ID: 8539857
    [No Abstract] [Full Text] [Related]

  • 14. Adjunctive azathioprine and antilymphocyte serum immunosuppression with cyclosporine.
    Ford HR, Fryd DS, Canafax DM, Ascher NL, Dunn D, Sutherland DE, Najarian JS, Simmons RL.
    Transplant Proc; 1988 Jun 27; 20(3 Suppl 3):8-12. PubMed ID: 3291316
    [No Abstract] [Full Text] [Related]

  • 15. Optimization of cyclosporine monotherapy--long-term graft function.
    Birkeland SA, Elbirk A, Rohr N, Jørgensen KA.
    Transplant Proc; 1994 Oct 27; 26(5):2501-6. PubMed ID: 7940767
    [No Abstract] [Full Text] [Related]

  • 16. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality.
    Light JA, Aquino A, Ali A, Rodriguez R, Ali S.
    Transplant Proc; 1987 Feb 27; 19(1 Pt 3):1927-30. PubMed ID: 3547897
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
    Guttmann RD, Flemming C.
    Clin Transplant; 1997 Jun 27; 11(3):185-92. PubMed ID: 9193840
    [Abstract] [Full Text] [Related]

  • 19. Cadaveric renal transplant without prophylactic prednisone therapy.
    Bry W, Warvariv V, Bohannon L, Feduska N, Straube B, Collins G, Levin B.
    Transplant Proc; 1991 Feb 27; 23(1 Pt 2):994-6. PubMed ID: 1989357
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of antithymocyte globulin antirejection treatment in renal transplant patients with either cyclosporine or azathioprine as basic immunosuppression.
    Hoitsma AJ, Wetzels JF, Berden JH, Koene RA.
    Transplant Proc; 1987 Oct 27; 19(5):3589-91. PubMed ID: 3313864
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.